← Open Payments lookup

MILDRED ONIME: Open Payments

NPI 1609282391 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,488 in 68 payments from 29 companies in 2025. Trend: 2023 $340 · 2024 $632 · 2025 $2,488

Food & beverage: $1,488Long term medical supply or device loan: $798Education: $203
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation12$896
Incyte Corporation4$170
Janssen Biotech, Inc.5$169
Stemline Therapeutics Inc.3$145
Lilly USA, LLC5$134
Daiichi Sankyo Inc.4$127
Gilead Sciences, Inc.1$93
Celgene Corporation2$67
PharmaEssentia USA Corporation2$65
E.R. Squibb & Sons, L.L.C.2$57

Products named: KISQALI, ELZONRIS, RYBREVANT, Enhertu, BESREMI, OPDIVO, MONOFERRIC, VERZENIO.

Industry payments across TX — which companies pay providers there.